US firm to market breast milk

Professur

Well-Known Member
US firm to market breast milk
By Lester Haines
Published Thursday 4th August 2005 12:27 GMT
Get breaking Reg news straight to your desktop - click here to find out how
A US firm has announced that it wants to buy breast milk and then flog it to hospitals for the treatment of sick babies. LA-based Prolacta Bioscience has set its sights on stocks at independent milk banks which it will pasteurise and supply for the treatment of underweight rugrats, the BBC reports.

Naturally, Prolacta's primary concern is the welfare of said mewling infants. It also intends to "carry out research to develop breast milk-based therapies". As Prolacta supremo Elena Medo notes: "Human breast milk is really an incredible therapy. Let's try to develop processes where we can preserve every bit of its nutrients and the potent antiviral and all of its diseases fighting properties."

But despite these noble sentiments, some have reservations. The Human Milk Banking Association of North America (great name - tell it like it is) has questioned the possible trade in human milk, saying that "introducing the profit motive might pressure women and medical institutions to provide milk to a bank regardless of the needs of their own babies".

On this side of the Pond, Rosie Dodds of the National Childbirth Trust chipped in: "There is a need for more mothers to come forward to give their milk, the whole issue needs to be valued more. I can see both sides of the argument. However, I don't think it would work in the UK as it would prove too expensive for hospitals."

Too expensive? Ms Dodds seems to think that human breast milk grows on trees. Listen - there's a cost implication here: production; transportation; marketing. Then, of course, there's the breast-milk-therapy R&D budget, execs' salaries and let's not forget the shareholders who - in common with premature babies - want to get fat on goodness-packed mam juice.

Still, capitalism is capitalism, so here are a few other money-spinners for Prolacta:

Mouth dry? Don't fret - our 100 per cent organic bottled saliva instantly solves that "morning after" feeling.
Lack of vaginal lubrication? Try our "Swedish Nymphette" range of natural remedies.
Need extra elbow grease? Tinned Bolivian hard graft exclusively imported from the tin mines of the Andes.
Short of cash? Ask yourself how much bone marrow your kids really need then call 0666-GREE-D.

Source


I'm sending in my resume for quality control specialist.
 
Analysis: Oregon Breast Milk Contaminated

PORTLAND, Ore. - The breast milk of Oregon women is contaminated with a high level of toxic flame retardants known as PBDEs, researchers say.

A new analysis by the California Environmental Protection Agency and the Seattle-based research group Northwest Environment Watch compared the PBDE levels in the breast milk of 40 Pacific Northwest mothers with the levels of another toxin and chemical cousin, PCB.

Polybrominated diphenyl ethers, or PBDEs, are used as a flame retardant while polychlorinated biphenyls, or PCBs, are a class of chemicals used in insulating fluids for electrical equipment before they were banned in the late 1970s after studies indicated they cause cancer.

The analysis of breast milk samples showed that 30 percent of the mothers tested in the Northwest study had higher levels of PBDEs than PCBs.

The analysis, released Thursday at the "Dioxin 2005" international conference in Toronto, suggests that PBDE contamination may be surpassing the level of PCB contamination in humans and the environment.

"The comparison with PCBs suggests that toxic flame retardants have emerged as a major environmental health concern," said Clark Williams-Derry, research director for Northwest Environment Watch.

The breast milk samples from Northwest women were analyzed in the California EPA's Hazardous Materials Laboratory in Berkeley, Calif. It is one of several studies under way on breast milk contamination.

Some of the data from the study was originally released by Northwest Environment Watch in 2004, but the comparison of contamination levels was just completed, researchers said.

The 40 mothers in the Northwest study are from Oregon, British Columbia, Montana and Washington state.

Overall, they had levels of PBDEs 20 to 40 times higher than levels found in women from Europe and Japan.

Source


Sounds like a market just openned up.
 
Back
Top